GREGORY C DOWLING
Allopathic & Osteopathic Physicians|Family Medicine FORT WAYNE, IN NPI 1487916698
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine IN ABBVIE INC. All categories
General Payments — all program years on this page
$9,269.41
- Category: General Payments
- Program years: PY2018–2024
- Record count: 745
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,767.37 across 138 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,767.37 | 138 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $390.02 | 52 |
| PFIZER INC. | $230.07 | 22 |
| Acerta Pharma LLC | $210.14 | 7 |
| Lilly USA, LLC | $208.05 | 15 |
| Novo Nordisk AS | $166.73 | 10 |
| Corium, Inc. | $54.42 | 3 |
| SHIELD THERAPEUTICS INC | $53.97 | 2 |
| Lundbeck LLC | $53.38 | 3 |
| Sumitomo Pharma America, Inc. | $43.04 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $37.98 | 2 |
| Merck Sharp & Dohme Corporation | $35.93 | 2 |
| Astellas Pharma US Inc | $31.09 | 2 |
| Amgen Inc. | $28.93 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $28.66 | 2 |
| UCB, Inc. | $27.57 | 1 |
| IRONSHORE PHARMACEUTICALS INC. | $20.75 | 1 |
| Abbott Laboratories | $16.59 | 1 |
| Axsome Therapeutics, Inc. | $16.59 | 1 |
| Neurocrine BioSciences, Inc. | $16.20 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $15.06 | 1 |
| GlaxoSmithKline, LLC. | $14.54 | 1 |
| DEXCOM, INC. | $14.04 | 1 |
| Tris Pharma Inc | $14.01 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $13.29 | 1 |
| Exact Sciences Corporation | $13.23 | 1 |
| SANOFI-AVENTIS U.S. LLC | $13.09 | 1 |
By program year
Records — PY2024 (138)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.